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SPECTAbstract Background: Abnormality of left ventricular (LV) diastolic function is frequently the
earliest indicator of LV dysfunction in many diseases, including coronary artery disease (CAD),
and hypertension. Electrocardiography (ECG)-gated technetium (Tc)-99 m tetrofosmin single-
photon emission computed tomography (SPECT) has been reported to be a useful method for
evaluation of LV function.
Objectives: The purpose of this study was to assess the impact of hypertension on diastolic left ven-
tricular function using ECG-gated Tc-99m tetrofosmin SPECT.
Methods: Thirty consecutive patients with normal exercise myocardial perfusion and normal LV
systolic function, were studied out of 233 patients underwent ECG-gated Tc-99m tetrofosmin
SPECT at our institution between January 2012 and December 2013. Patients were divided into
two groups according to the presence or absence of systemic hypertension (blood pressure P140/
90 mm Hg on P3 measurements or treatment with antihypertensive medication). Parameters of
diastolic LV function were assessed.
Results: Of the studied 30 patients, 19/30 (63%) had hypertension. There was no difference with
respect to age, gender, LV end-diastolic volume (EDV), LV end-systolic volume (ESV), and LV
ejection fraction values obtained by quantitative gated SPECT between patients with and without
hypertension. The ﬁrst-third mean ﬁlling rate (1/3 MFR), peak ﬁlling rate (PFR) of patients with
hypertension (1.22 ± 0.38, 2.83 ± 1.10 EDV/s) were lower than those of patients without
600 M.H.M. Sayed et al.hypertension (1.54 ± 0.30, 2.90 ± 0.35 EDV/s), and the time to peak ﬁlling (TTPF) of patients
with hypertension (199.42 ± 68.34 ms) was higher than TTPF of patients without hypertension
(164.90 ± 36.39 ms).
Conclusions: Quantitative ECG-gated Tc-99m tetrofosmin SPECT reveals that hypertensive
patients with preserved global LV systolic function may have signiﬁcant changes in diastolic LV
function. Gated myocardial perfusion SPECT reports are always lacking in these changes in diasto-
lic function. We recommend inclusion of such changes in diastolic function in gated myocardial per-
fusion SPECT reports that can help in proper management of hypertensive patients.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Left ventricular diastolic dysfunction (LVDD) is recognized as
an important contributor to diastolic heart failure and is asso-
ciated with increased morbidity and mortality (1).
Hypertension and cardiac ischemia are the most common
causes of diastolic heart failure (2). Abnormalities of left ven-
tricular (LV) diastolic ﬁlling have often been described in
patients with hypertension (3–9), even in the absence of LV
hypertrophy (4,7–9). Diastolic dysfunction in hypertensive
patients is characterized primarily by impaired isovolumic
relaxation (8,10). As a consequence, the velocity of early diasto-
lic ﬁlling decreases and the late atrioventricular gradient
increases, yielding a decreased early/atrial (E/A) velocity ratio
(11). The evaluation of LV diastolic function as part of routine
echocardiographic testing is recommended by the current guide-
lines of the American Society of echocardiography and the
European Association of cardiovascular imaging (12). Several
reports have shown that Electrocardiography (ECG)-gated sin-
gle-photon emission computed tomography (SPECT) was
found to have good correlation with echocardiography for
assessment of diastolic and systolic LV function and volumes
(13–16). In clinical practice, ECG-gated SPECT may be a good
alternative for patients with limitations for optimal echocardio-
graphy visualization (13), and the stability of diastolic function
variables estimated by ECG-gated SPECT has been reported
recently (17). The purpose of this study was to assess the impact
of hypertension on diastolic left ventricular function using
ECG-gated Tc-99m tetrofosmin SPECT.
2. Patients and methods
Following approval by the institutional ethics committee,
medical records of all consecutive patients underwent ECG-
gated Tc-99m tetrofosmin SPECT at our institution between
January 2012 and December 2013 were reviewed. An informed
consent was waived for this retrospective study. Inclusion cri-
teria for current study were patients with normal exercise
myocardial perfusion, normal LV systolic function, and no his-
tory of arrhythmia (atrial ﬁbrillation, ventricular premature
contraction and atrial premature contraction), valvular or
other cardiac disease.
Patients were divided into two groups according to the
presence or absence of systemic hypertension (blood pressure
P140/90 mm Hg on P3 measurements or treatment with
antihypertensive medication).Patients underwent rest/adenosine pharmacological stress
(50%) or rest/treadmill stress (50%) MPI one day protocol.
8–10 mCi of Tc-99m tetrofosmin was injected at rest and
ECG-gated rest SPECT (imaging) was initiated after 45–
60 min. 4 h later, adenosine infusion started at 140 lg/kg/min
over a 6-min period, or treadmill exercise test according to
Bruce protocol. Blood pressure measurement (every minute)
and 12-lead electrocardiogram were obtained and the patient’s
symptoms were recorded. 24–30 mCi of Tc-99m tetrofosmin
was injected during adenosine infusion (at 3 min of a 6-min
infusion protocol), or at peak exercise during treadmill stress,
and ECG-gated stress SPECT imaging was initiated 30–45 min
later.
Images were acquired with a dual-head gamma camera
(Forte, Philips Medical Systems) equipped with a VXHR
(Vantage extra high-resolution) collimator using a 20% win-
dow centered over the 140-keV photopeak. Gamma camera
heads are mounted at 90, and acquisition parameters used a
64 · 64 matrix, a contour orbit, an elliptic 180 acquisition
arc (45 right anterior oblique to 45 left posterior oblique)
with 64 projections at 25 s per projection and 16 frames per
cardiac cycle.
The summed projection data sets were reconstructed into
tomographic transaxial images using ﬁltered backprojection
with a Butterworth ﬁlter (order, 5; cutoff frequency, 0.66
cycle/pixel), and automatic reorientation. No attenuation or
scatter correction was used.
The LVEF and LV volumes and diastolic functional
parameters including the peak-ﬁlling rate (PFR), the ﬁrst-third
mean ﬁlling rate (1/3 MFR), the time to peak ﬁlling (TTPF)
were calculated using AutoQUANT software (Cedars-Sinai
Medical Center, Los Angeles, California, USA) from gated
SPECT images. The LV end-diastolic volume (EDV), LV
end-systolic volume (ESV), and LV ejection fraction (LVEF)
were calculated from the LV volume/time curve. The LV ﬁlling
rate/time curve is computed from the ﬁrst derivative of the vol-
ume/time curve. The peak-ﬁlling rate (PFR), expressed in
EDV/s, is the greatest ﬁlling rate in early diastole and corre-
sponds to the peak value of the ﬁrst derivative of the diastolic
portion of the time-activity curve, normalized to EDV. The
time to peak ﬁlling (TTPF), expressed in milliseconds, is the
interval between end-systole and the PFR. The ﬁrst-third mean
ﬁlling rate (1/3 MFR), expressed in EDV/s, is the mean ﬁlling
rate during the initial one-third of diastolic time. An example
of the volume/time and ﬁlling/time curves combined display
is shown in Fig. 1.
Fig. 1 Example of a patient’s volume and ﬁlling curves over time
in 16-frame gated MPS. Numbers in brackets represent exact
frame numbers from which parameters are derived. PER, peak
ejection rate; EDV, end diastolic volume; PFR, Peak ﬁlling rate.
BPM, beats per minute; MFR/3, mean ﬁlling rate over ﬁrst third
of diastole; TTPF, time to peak ﬁlling; ESV, end systolic volume.
Table 1 Comparisons of clinical characteristics, and ECG-
gated Tc-99m tetrofosmin SPECT functional parameters
between hypertensive and normotensive patients.
Parameter Hypertensive
group
Normotensive
group
P
value
Number 19 (63%) 11 (37%)
Age 63.6 ± 12.9 54.4 ± 16.4 N.S.
Sex
Male 10 3 N.S.
Female 9 8
Diabetes
mellitus
10/19 (53%) 5/11(45%) N.S.
HR
Stress 81.5 ± 12.3 76.91 ± 7.9 N.S.
Rest 77.56 ± 11.57 76.91 ± 9.23 N.S.
LVEF
Stress 64.3 ± 7.4 66.5 ± 7 N.S.
Rest 65.1 ± 9.3 66.1 ± 6.7 N.S.
LVEDV
Stress 80.2 ± 18.4 85.4 ± 27.9 N.S.
Rest 80.72 ± 16.42 86.4 ± 26 N.S.
LVESV
Stress 29.6 ± 11.2 30 ± 13.6 N.S.
Rest 29.94 ± 10.9 30.2 ± 13.9 N.S.
1/3 MFR
Stress 1.22 ± 0.38 1.54 ± 0.3 <0.05
Rest 1.3 ± 0.3 1.53 ± 0.36 N.S.
PFR
Stress 2.83 ± 1.10 2.9 ± 0.35 <0.05
Rest 2.80 ± 0.9 2.92 ± 0.5 N.S.
TTPF
Stress 199.42 ± 68.34 164.90 ± 36.39 N.S.
Rest 190.68 ± 68.25 158.91 ± 29.7 N.S.
HR, heart rate; LVEF, left ventricular ejection fraction; LVEDV
left ventricular end-diastolic volume; LVESV, left ventricular end-
systolic volume; 1/3 MFR, ﬁrst-third mean ﬁlling rate; PFR, peak
ﬁlling rate; TTPF, time to peak ﬁlling; N.S., nonsigniﬁcant.
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Quantitative data were expressed as mean ± standard devia-
tion, and qualitative data were expressed in percentage.
Statistical analysis of the categorical variables was conducted
using a Chi-square test or Fisher’s exact test. Comparisons
between continuous variables were performed with an
independent t test, and single comparisons were performed
with Student’s paired t test. A p value of <0.05 was considered
statistically signiﬁcant. All the analyses were performed using
SPSS version 20.0 (SPSS Inc., Chicago, IL, USA).
3. Results
Out of 233 patients underwent ECG-gated Tc-99m tetrofosmin
SPECT at our institution between Jan 2012 and Dec 2013,
thirty consecutive patients (17 female and 13 male) with nor-
mal exercise myocardial perfusion and normal LV systolic
function were included in current study. Their age range was
33–86 years (mean age, 60.23 ± 14.74 years). None had a his-
tory of valvular or other cardiac disease.
Patients were referred for ECG-gated Tc-99m tetrofosmin
SPECT to rule out suspected CAD. The indications for
ECG-gated Tc-99m tetrofosmin SPECT were atypical chest
pain (n= 17), shortness of breath with or without atypical
chest pain (n= 11), and preoperative cardiac-risk assessment
for non-cardiac surgery (n= 2). During stress testing, none
had a positive ECG response (>1-mm ST segment
depression).
Of the studied 30 patients, 19/30 (63%) had hypertension.
There was no difference with respect to age, gender, LV end-
diastolic volume (EDV), LV end-systolic volume (ESV), andLV ejection fraction values obtained by quantitative gated
SPECT between patients with and without hypertension.
Comparisons of clinical characteristics, and ECG-gated Tc-
99m tetrofosmin SPECT functional parameters between
hypertensive and normotensive patients are summarized in
Table 1.
The ﬁrst-third mean ﬁlling rate (1/3 MFR), peak ﬁlling rate
(PFR) after stress test of patients with hypertension
(1.22 ± 0.38, 2.83 ± 1.10 EDV/s) were statistically signiﬁcant
lower than those of patients without hypertension
(1.54 ± 0.30, 2.90 ± 0.35 EDV/s) (P< 0.05), and the time
to peak ﬁlling (TTPF) of patients with hypertension
(199.42 ± 68.34 ms) was higher than TTPF of patients with-
out hypertension (164.90 ± 36.39 ms) (P= ns).
In the hypertensive group (n= 19), the heart rate (HR)
after stress was signiﬁcantly higher than at rest
(81.5 ± 12.3 b.p.m. vs. 77.56 ± 11.57 b.p.m.; P= 0.004), but
LVEDV, LVESV, LVEF, 1/3 MFR, PFR, and TTPF were
comparable between after stress and at rest (LVEDV
602 M.H.M. Sayed et al.80.2 ± 18.4 ml vs. 80.72 ± 16.42 ml, LVESV 29.6 ± 11.2 ml
vs. 29.94 ± 10.9 ml, 1/3 MFR 1.22 ± 0.38 EDV/s vs.
1.3 ± 0.3 EDV/s, PFR 2.83 ± 1.10 EDV/s vs. 2.80 ± 0.9
EDV/s, and TTPF 199.42 ± 68.34 ms vs. 190.68 ± 68.25 ms).
In the normotensive group (n= 11), HR, LVEDV,
LVESV, LVEF, 1/3 MFR, PFR, and TTPF were comparable
between after stress and at rest (HR 76.91 ± 7.9 b.p.m. vs.
76.91 ± 9.23 b.p.m., LVEDV 85.4 ± 27.9 ml vs.
86.4 ± 26 ml, LVESV 30 ± 13.6 ml vs. 30.2 ± 13.9 ml, 1/3
MFR 1.54 ± 0.3 EDV/s vs. 1.53 ± 0.36 EDV/s, PFR
2.9 ± 0.35 EDV/s vs. 2.92 ± 0.5 EDV/s, and TTPF
164.90 ± 36.39 ms vs. 158.91 ± 29.7 ms).4. Discussion
Several studies have shown a high prevalence of LVDD in
patients with hypertension (4,18–21) even in the absence of
alteration of LV systolic function (22,23), including newly
diagnosed patients who are clinically asymptomatic (24). Left
ventricular diastolic dysfunction has been shown to be asso-
ciated with increased cardiovascular morbidity and mortality,
as well as the development of heart failure (25), thus rendering
its recognition important for the assessment of hypertensive
persons. ECG-gated SPECT has been reported to be a useful
method for evaluation of LV function. The 1/3 MFR, PFR,
and the TTPF are the most commonly reported parameters
for assessing LVDF in ECG-gated SPECT. We retrospectively
assessed these parameters in ‘‘hypertensive and normotensive’’
patients early after maximal exercise, and during rest.
The results of this study demonstrated that 1/3 MFR mea-
sured by quantitative ECG-gated Tc-99m tetrofosmin SPECT
after stress of patients with hypertension (1.22 ± 0.38 EDV/s)
was signiﬁcantly lower than that of patients without hyperten-
sion (1.54 ± 0.30 EDV/s). Mizunobu et al. (14) reported simi-
lar mean values of 1/3 MFR for patients with mild diastolic
dysfunction, and patients with normal diastolic function esti-
mated by ultrasound echocardiography (UCG) (1.01 ± 0.35
EDV/s, and 1.43 ± 0.37 EDV/s respectively). Furthermore,
the 1/3 MFR of patients with mild diastolic dysfunction esti-
mated by UCG was signiﬁcantly lower than that of patients
with normal diastolic function.
The peak ﬁlling rate measured by quantitative ECG-gated
Tc-99m tetrofosmin SPECT after stress of patients with hyper-
tension (2.83 ± 1.10 EDV/s) was also lower than that of
patients without hypertension (2.90 ± 0.35 EDV/s). The mean
value for PFR of hypertensive and normotensive patients in
current study was higher than the mean value of PFR reported
in prior studies for patients with mild diastolic dysfunction and
normal study population (14,17). Akincioglu et al. (17)
assessed the values of diastolic function parameters in 90
patients with normal exercise gated SPECT, and no history
of hypertension, diabetes, rest electrocardiogram abnormality,
or known cardiac disease, and reported a mean normal value
for PFR of 2.62 ± 0.46 EDV/s. Mizunobu et al. (14) also
reported that the PFR of patients with mild diastolic dysfunc-
tion estimated by UCG (1.85 ± 0.57 EDV/s) was signiﬁcantly
lower than that of patients with normal diastolic function
(2.43 ± 0.56 EDV/s). The divergence with these studies could
be explained based on that most of patients in our study pop-
ulation were females (57%), compared to 21% in Akincioglu
et al. (17) study and 44% in Mizunobu et al. (14) study.Akincioglu et al. (17) reported a mean value for PFR of nor-
mal women (2.95 ± 0.54 EDV/s), similar to PFR of nor-
motensive patients in current study. Also, PFR has been
reported to vary with other parameters, such as HR, EDV,
ESV, LVEF, and age (17,26). Variations in HR preferentially
affect diastolic rather than systolic time intervals, so they can
profoundly affect diastolic functions measurements (27).
Both EDV and ESV were reported to be lower and LVEF
and PFR were reported to be higher in women. A decrease
of PFR with aging was also observed (17). The differences in
these parameters between previous studies and current study
can explain the divergence of PFR with these studies.
The ﬁrst-third mean ﬁlling rate, and PFR obtained by
quantitative ECG-gated SPECT correlated positively with a
ratio of peak early transmitral ﬂow velocity to atrial ﬂow
velocity (E/A ratio) and negatively with pulmonary venous
inﬂow systolic/diastolic (S/D ratio) obtained by UCG as dia-
stolic functional parameters (16). Our results are in line with
the ﬁndings of Andersen et al. (28), who studied the impact
of essential hypertension and diabetes mellitus on left ventricu-
lar systolic and diastolic performance, and found that E/A
ratio was signiﬁcantly lower in hypertensive group compared
to control group.
The time to peak ﬁlling of patients with hypertension
(199.42 ± 68.34 ms) was higher than TTPF of patients with-
out hypertension (164.90 ± 36.39 ms). The mean value for
TTPF of patients without hypertension is similar to those
reported by Akincioglu et al. (17) for TTPF in normal study
population (164.6 ± 21.7 ms). They also reported TTPF as a
more stable diastolic function variable, as it did not correlate
with any of the systolic function parameters, age, or HR.
The time to peak ﬁlling derived from quantitative ECG-
gated SPECT correlated excellently with the Doppler LV
isovolumic relaxation time (IRT) (15). In accordance with
our ﬁndings, Andersen et al. (28) found that IRT was signiﬁ-
cantly higher in hypertensive group compared to control
group.
In current study, LVEDV, LVESV, LVEF, 1/3MFR, and
PFR were comparable between after stress and at rest in both
hypertensive and normotensive groups. These results are in
line with those reported by Nakae et al. (29) for the group of
patients with normal myocardial perfusion.
4.1. Limitations
In current study no direct correlation with echocardiography
was done, as most of our patients had their echocardiography
at an outside facility, and we only correlate our results with
previous studies. The small number of patients is another
limitation.
5. Conclusions
Quantitative ECG-gated Tc-99m tetrofosmin SPECT reveals
that hypertensive patients with preserved global LV systolic
function may have signiﬁcant changes in diastolic LV function.
Gated myocardial perfusion SPECT reports are always lacking
in these changes in diastolic function. We recommend inclu-
sion of such changes in diastolic function in gated myocardial
perfusion SPECT reports that can help in proper management
of hypertensive patients.
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